Announced Mon, 29 Jun · 15:15 IST
Trading window closed from July 1 ahead of Q1 FY27 results
Compliance View source PDF
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-3.9%1-day move
₹80.00
prior close
—
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
————-3.9-2.5-1.8-2.5-7.4-13.8-17.0———
Up moveDown movePending
AI summary
Novelix Pharmaceuticals (formerly Trimurthi Limited) has informed BSE that the trading window for dealing in its shares will remain closed for designated persons and their relatives from Wednesday, July 1, 2026, until 48 hours after the declaration of unaudited financial results for the quarter ending June 30, 2026. This is a routine SEBI PIT Regulations compliance measure ahead of the quarterly results announcement.
Likely market impact
Routine compliance filing; no impact on shareholders. Signals upcoming Q1 FY27 results announcement.